Zentalis Pharmaceuticals, Inc.

NASDAQ:ZNTL

Biotechnology

Healthcare
$1.36 +0.83%

+$0.03 today

Market cap
$133.64M
Beta
1.98
P/E (TTM)
-2.1
EPS (TTM)
-$1.77
52W Low $1.13High $6.95

Volume 1.45M

Average 2.00M

Price history

Zentalis Pharmaceuticals, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+2.26%

Period high

$6.61

Period low

$1.30

Latest

$1.36

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
10-QNov 9, 2026Nov 9, 2026
8-KNov 9, 2026Nov 9, 2026
SC 13G/AOct 27, 2026Oct 27, 2026
4Oct 1, 2026Oct 1, 2026
4Aug 19, 2026Aug 19, 2026
SC 13G/AAug 19, 2026Aug 19, 2026
424B5Aug 14, 2026Aug 14, 2026
8-KAug 14, 2026Aug 14, 2026
424B5Aug 13, 2026Aug 13, 2026
SC 13G/AAug 13, 2026Aug 13, 2026
10-QAug 6, 2026Aug 6, 2026
8-KAug 6, 2026Aug 6, 2026
SC 13GJul 30, 2026Jul 30, 2026
4Jun 18, 2026Jun 18, 2026
4Jun 18, 2026Jun 18, 2026

Competitors

Who does Zentalis Pharmaceuticals, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about ZNTL's filings, answered from its disclosures.

What is the latest ZNTL filing?

The latest filing shown is 8-K dated Nov 9, 2026.

How many recent filings does ZNTL have?

Intrinsic Alpha currently shows 20 recent filings for ZNTL.